A year ago, we announced the inception of Allogene Therapeutics at the Jefferies IO Cell Therapy Summit. Today we are back where it all began. Hear from CEO Dr. David Chang as he reflects on all we've accomplished in our first year: bit.ly/2I08i9I JefferiesEvents $ALLO

When I first met David, I knew he had a unique vision for the future of cancer. Proud to see a colleague and friend on the cover of @LifeSciLeader1 this month, but even more proud of the work we're doing at Allogene to revolutionize cell therapy. Congratulations David!

To all of my friends and colleagues in the healthcare community and beyond, I felt it was important to share this message with you. We have to look out for each other and be each other's champion. Be well my friends. Arie

Thanks for the well wishes! I am doing well & happy my #ALLO colleagues remain asymptomatic. I credit my T cells for fighting those little bugs🦠But my wife Rebecka wants to strangle me because I am stir crazy! Let’s keep each other sane and solve this together! Be well Arie

A new milestone in the history of cancer treatment: Allogene Therapeutics reported positive initial data in the Phase 1 ALPHA study in relapsed/refractory non-Hodgkin #lymphoma at this year’s #ASCO20. Congratulations to this incredible team.

As a former fellow, I am proud Society for Immunotherapy of Cancer has established the Rosenberg Scholars Fund to honor my friend and mentor, Dr. Steve Rosenberg. I have no doubt the next generation will be equally inspired by his extraordinary achievements in science. #SITC2020

A new group of deeply experienced startup execs has formed a circle around a new stab at oncolytic viruses hatched in the lab of one of the most experienced scientists operating in the field. endpts.com/a-veteran-onco…

Congratulations IconOVir Bio for your launch with $77M in Series A financing! The IconOVir team is made up of some of the most innovative scientists and researchers with a to pioneer the next generation of oncolytic virus therapy. bwnews.pr/358HhdR

My friend and mentor Dr. Steven Rosenberg fueled my early interest in immunotherapy, so it is with great joy I celebrate his achievements today along with his receipt of the Dan David Prize in Molecular Medicine. Congratulations to all the co-laureates on this tremendous honor.

John was a brilliant life science leader and trusted advisor. Our bond was formed through a shared passion for science, but grew deeper as our families grew in friendship. Forever be grateful for our time. On behalf of the Belldegrun/Funt family, you will be missed, my friend.

John was a brilliant life science leader and trusted advisor. Our bond was formed through a shared passion for science, but grew deeper as our families grew in friendship. On behalf of the Belldegrun/Funt family, you will be missed, my friend. bit.ly/3dqA2kS

Thank you FiercePharma for this recognition and congratulations to my fellow nominees. It is my utmost honor to work alongside the great minds in this industry and progress science to make a life-changing difference for patients.

We are proud to announce the launch of #CARTTogether: a first-of-its-kind effort with leading clinicians to champion the advancement of #allogeneic #CART investigational products. Learn more. $ALLO #immunotherapy

David Bonderman: my business partner, my mentor, my friend. linkedin.com/posts/arie-bel…

2017 will be a year of revolutions in cell therapy. Read my new blog on what it means for science & patients #KitePharma $KITE x.com/KitePharma/sta…

Today is an important day for CAR-T therapy. Read here about my thoughts on Novartis FDA Ad Comm. $Kite Kite, a Gilead Company x.com/KitePharma/sta…

Read more about my thoughts on this historic day with the first-ever approval of a CAR-T therapy from Novartis $Kite x.com/KitePharma/sta…

Proud to be a part of the next revolution in CAR T therapy with forward-looking partners Allogene Therapeutics bit.ly/2IpMHna

Read more about Allogene and our mission with allogeneic CAR T therapies Allogene Therapeutics bit.ly/2JhLxeD

Thrilled to be a part of #KronosBio and its pursuit for therapies against some of the most intractable cancer targets x.com/Vida_Ventures/…